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AbstractAlthough possible biological functions of whey acidic protein (WAP) have been suggested, few studies have focused on investigating the
function of WAP. This paper describes evidence for WAP function in lobulo-alveolar development in mammary glands in vivo and in the cell
cycle progression of mammary epithelial cells in vitro. Ubiquitous overexpression of WAP transgene impaired only lobulo-alveolar
development in the mammary glands of transgenic female mice but not other physiological functions, indicating that the inhibitory function
of WAP is specific to mammary alveolar cells. The forced expression of WAP significantly inhibited the proliferation of mouse mammary
epithelial cells (HC11 cells and EpH4/K6 cells), whereas it did not affect that of NIH3T3 cells. Co-culturing of WAP-clonal cells and control
cells using a transwell insert demonstrated that WAP inhibited the proliferation of HC11 cells through a paracrine action but not that of
NIH3T3 cells, and that WAP was able to bind to HC11 cells but not to NIH3T3 cells. Apoptosis was not enhanced in the HC11 cells with
stable WAP expression (WAP-clonal HC11 cells). BrdU incorporation and FACScan analyses revealed that cell cycle progression from the
G0/G1 to the S phase was inhibited in the WAP-clonal HC11 cells. Among G1 cyclins, the expression of cyclin D1 and D3 was significantly
decreased in the WAP-clonal HC11 cells. The present results provide the first documented evidence that WAP plays a negative regulatory role
in the cell cycle progression of mammary epithelial cells through an autocrine or paracrine mechanism in vivo.
D 2004 Elsevier Inc. All rights reserved.
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Whey acidic protein (WAP) has been found in the milk of
a limited number of species of rodents, including mice
(Hennighausen and Sippel, 1982a) and rats (Campbell et al.,
1984). In addition, WAP has been identified in camels (Beg
et al., 1984) and rabbits (Devinoy et al., 1988), and more
recently in the milk of pigs (Rival et al., 2001; Simpson et al.,
1998), wallabies (Simpson et al., 2000), red kangaroos
(Nicholas et al., 2001), and brush tail possums (Demmer et0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.04.040
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E-mail address: atojo@mail.ecc.u-tokyo.ac.jp (H. Tojo).al., 2001). WAP gene expression occurs in mammary
epithelial cells during late pregnancy and throughout
lactation, and is regulated by a variety of lactogenic
hormones, including insulin, glucocorticoid, and prolactin
(Burdon et al., 1991a; Doppler et al., 1991; Vonderhaar and
Ziska, 1989). WAP proteins have a signal peptide (Dandekar
et al., 1982) and two domain structures that can be identified
at the four-disulfide core (4-DSC) domain, which is
composed of eight cysteine residues in a conserved arrange-
ment (Hennighausen and Sippel, 1982b). The 4-DSC
domain arrangement is not exclusive to the WAP family;
several other proteins containing 4-DSC domains have been
identified (Dandekar et al., 1982; Garczynski and Goetz,
1997; Heinzel et al., 1986; Kirchhoff et al., 1991; Wideow et
al., 1990), which contain either single or multiple copies of274 (2004) 31–44
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and may function as protease inhibitors (Larsen et al., 1998;
Ranganathan et al., 2000). Thus, based on the limited
sequence identity with known protease inhibitors, it has been
postulated that WAP may also be a secreting protease
inhibitor (Nicholas et al., 1997; Ranganathan et al., 2000).
However, previous studies have demonstrated that rat WAP
does not exhibit any protease inhibitory activity in elastase I
and II and chymotrypsin assays (Burdon et al., 1991b).
Transgenic mothers in which a mouse genomic WAP
transgene is expressed precociously have significantly
impaired development of the mammary gland and have
failed to lactate (Burdon et al., 1991b; Shamay et al., 1992).
It has also been reported that high expression of WAP in
MMTV-LTR/WAP transgenic mice results in hyperplasia of
coagulation glands and impaired mammary development
(Hennighausen et al., 1994). On the other hand, Guntzberg et
al. (1991) and Wen et al. (1995) have reported, based on their
RT-PCR analyses, that WAP is expressed in various exocrine
tissues of lactating mice. Such findings suggest that WAP is
important as a nutrient in milk for growth, but that it also may
exert some other biological function not only in the
mammary gland but also in other tissues. To date, few
studies have investigated the true function of WAP. To
determine whether WAP functions in any tissue types other
than the mammary glands, we generated transgenic mice
ubiquitously expressing WAP and investigated their pheno-
types. WAP function was also investigated by an in vitro
system using mammary epithelial cells (HC11 cells). Here,
we report that the ubiquitous and forced production of WAP
not only inhibits lobulo-alveolar development in vivo but
also the cell cycle progression of HC11 cells in vitro.Materials and methods
Animals
Mice were purchased from a laboratory animal dealer
(SLC, Shizuoka, Japan) and were housed under regulated
temperature (22–258C), humidity (40–60%), and illumina-
tion cycles (14-h light, 10-h dark); food and water were
supplied ad libitum. The experiments were conducted
according to the Guidelines for the Care and Use of
Laboratory Animals from the University of Tokyo College
of Agriculture.
Gene construction
Mouse WAP cDNA was made by reverse transcription
using total RNAs that were extracted from the mammary
glands of C57BL/6J female mice in late pregnancy using
Trizol Reagent (Gibson BRL) according to the manufactur-
er’s instructions. PCR was carried out using the following
primers: 5V-ATG-CGT-TGC-CTC-ATC-AGC-C-3V (for-
ward) and 5V-GAC-AGG-CAG-GGA-TGG-C-3V (reverse).A 452-bp segment of the WAP cDNA was inserted into a
pGEM-T Easy vector (Promega) and amplified. We deter-
mined the DNA sequences of the PCR products and judged
the results to indicate a complete cDNA encoding of the full
open reading frame of mouse WAP. EGFP in pCX-EGFP
plasmid (kindly provided byDr.M.Okabe, OsakaUniversity,
Japan) was excised, and in turn replaced by the EcoRI/EcoRI
WAP cDNA fragment (452 bp). The pCX-WAP plasmid
contained an enhancer of cytomegalo virus, a chicken h-actin
promoter with splicing sequences, WAP cDNA, and the
rabbit h-globin 3V flanking sequences. For the production of
transgenic mice, the SspI/HindIII DNA fragment (2.98 kb)
was excised from a pCXN-WAP and separated by electro-
phoresis using a 1% agarose gel, and then purified by CsCl
ultracentrifugation according to the method of Hogan et al.
(1994). For the transfection of plasmids into cultured cells,
pCXN-WAP plasmid, pCXN-EGFP plasmid as a marker
gene, and pCXN plasmid without the coding region as an
empty plasmid (mock) were used, respectively.
CAG/WAP transgenic mice
The purified DNA fragment (approximately 2000 copies)
was microinjected using standard methodology into the
pronucleus of BDF1 (C57BL/6XDBA/2) eggs (Hogan et al.,
1994). The pups were screened for the transgene by PCR
and Southern blot analysis of genomic DNA obtained from
the tip of the tail. The primers 5V-ATG-CGT-TGC-CTC-
ATC-AGC-C-3V (forward) and 5V-GAC-AGG-CAG-GGA-
TGG-C-3V (reverse) were used for the detection of WAP
cDNA by PCR, and WAP cDNA labeled with 32P a-dCTP
was used as a probe for Southern blot analysis.
Whole mounts of mammary glands
The third thoracic mammary glands were removed from
the transgenic and control mice. Each mammary gland was
dissected from the inner surface of the skin, retaining some
of the peripheral connective tissues, spread on a cork board,
and fixed in freshly prepared Bouin’s solution. The glands
were then defatted overnight in acetone. The whole mounts
were stained with Mayer’s hematoxylin, embedded in
Canadian balsam, and photographed.
Histological examination of mammary glands
Tissues were embedded in optimal cutting temperature
compound (Sakura Finetechnical) and frozen in liquid
nitrogen. Frozen sections, 5-Am thick, were mounted on
vectabond-coated slides and fixed in 3% paraformaldehyde
in PBS (pH 7.4) for 15 min at room temperature. The
sections were then blocked with 0.3% H2O2 in methanol for
30 min at room temperature and then 8% skim milk at 48C
overnight. After washing with PBS (pH 7.4), the sections
were incubated with primary antibodies, anti-WAP rabbit
serum in a 1/100 dilution with 1% BSA in PBS for 1 h. The
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40 min with the biotin-labeled mouse anti-rabbit secondary
antibody (B5283) (Sigma) in a 1/400 dilution. Signals were
detected by the horseradish-peroxidase-labeled avidin–bio-
tin complex (ABC)-mediated method (Vector Laboratories)
using diaminobenzidine (DAB) as a substrate. To avoid
background staining, slides were preincubated with 10%
rabbit serum for 30 min before incubation for 18 h at 48C
with the specific antibody directed against mouse WAP.
Northern blot analysis
RNAwas extracted from the tissues using Trizol Reagent
(Gibco BRL) according to the manufacturer’s instructions.
Total RNA (10 Ag) was fractionated through a 2% agarose
formaldehyde gel, transferred to a nylon membrane (Pall
Biosupport), and then cross-linked by exposure to ultra-
violet irradiation. The membrane was prehybridized, hybri-
dized with the mouse WAP cDNA labeled with 32P a-dCTP,
and then washed twice in 2 SSC/0.1% SDS at room
temperature, followed by a wash in 0.2 SSC/0.1% SDS at
658C. The signals were visualized by exposure of the
membrane to X-ray film (Fuji Film).
Antibodies
For the immunoblotting experiments, goat antibody
against mouse WAP (Jackson Immune Research Lab),
mouse antibodies against human cyclin D1 and Cdk4
(Santa Cruz Biotechnology), and rabbit antibody against
human cyclin D3 and cyclin E (Santa Cruz Biotechnology)
were used as the primary antibodies. Anti-mouse, anti-
rabbit, and anti-goat IgG conjugated with horseradish
peroxidase were used as the secondary antibodies.
Western blot analysis
Total protein was extracted from the cells by homoge-
nizing them in CytoBustor Protein Extraction Reagent
(Novagen) including 1 mM DTT, 0.5 mM PMSF, 2 Ag/ml
of aprotinin, 2 Ag/ml pepstatin, and 2 Ag/ml leupeptin; the
proteins were then collected by centrifugation. The protein
concentration of the extracts was determined using the
Bradford method (Bradford, 1976) and the samples were
used for Western blot analysis. The proteins were separated
on SDS-PAGE (10% or 15%) gel and transferred to a
membrane by semidry blotting. The membrane was blocked
for 1 h in phosphate-buffered saline (PBS) containing 3%
skim milk. After washing the membrane with PBS contain-
ing 0.1% Tween 20 (PBST), it was incubated with primary
antibody overnight at 48C. After washing with PBST, the
membrane was incubated with peroxidase-conjugated sec-
ondary antibody for 1.5 h at room temperature. After the
membrane had been washed with PBST, the specific
antibody signals were detected with ECL (Amersham
Pharmacia Biotech), followed by exposure to X-ray film.Cell culture
Two independent mammary epithelial cell lines derived
from mouse pregnant mammary glands were used: HC11
cells (kindly provided by Dr. R.K. Ball, Fredrich Miescher
Institute, Switzerland) (Ball et al., 1998) and EpH4K6 cells
(kindly provided by Dr. W. Birchmeier, Max-Delbritck-
Center, Berlin, Germany) (Niemann et al., 1998). NIH3T3
cells (American Type Culture Collection) from mouse fetal
cells were used as a control for comparison with the
mammary epithelial cells. The HC11 cells were grown in a
complete medium, RPMI1640 (Gibco BRL), containing
10% (v/v) heat-inactivated FBS, 5 Ag/ml of insulin, 10 ng/
ml of epidermal growth factor, and 50 Ag/ml of gentamicin.
The EpH4/K6 cells were grown in a complete medium,
Dulbecco’s Modified Eagle Medium (DMEM) (Gibco
BRL), containing 10% (v/v) heat inactivated FBS, 3.7 g/l
of NaHCO3, and 105 U/l of penicillin and gentamicin. The
NIH3T3 cells were grown in a complete medium, i.e.,
Dulbecco’s Modified Eagle Medium containing 10% (v/v)
heat-inactivated FBS, 100,000 U/l of penicillin, and 10 mg/l
of streptomycin. All cells were cultured in a humidified
atmosphere of 5% CO2 in air at 378C.
Transfection of plasmids
The plasmids were transfected by the use of the
Profection Mammalian Transfection System Calcium Phos-
phate (Promega) according to the manufacturer’s instruc-
tions. For the establishment of stable plasmid expression,
linearized plasmids were transfected into the cells and, after
culturing the cells in complete medium for 2 days, cells
demonstrating stable expression of plasmids were selected
by passing of the culture for 10 days in a complete medium
containing G418 (700 Ag). The efficiency of plasmid
transfection was confirmed by observing GFP expression
levels in the EGFP-transfected cells.
RT-PCR
One microgram of total RNA was denatured and
reverse-transcribed into cDNA using SuperScript II (Prom-
ega) in a reaction volume of 10 IU, according to the
manufacturer’s protocol. PCR was carried out, and the
products were then sequenced and confirmed to be the
appropriate transcript. We used the following primer
sequences for the amplification of target genes: 5V-ATG-
CGT-TGC-CTC-ATC-AGC-C-3V (forward) and 5V-GAC-
AGG-CAG-GGA-TGG-C-3V(reverse) for WAP cDNA; 5V-
CCT-GCA-TGT-TCG-TGG-CCT-CT-3Vand 5V-GAA-AGT-
GCG-TTG-TGC-GGT-AGC-3Vfor cyclin D1;5V-AGA-
CCT-TCA-TCG-CTC-TGT-GC-3Vand 5V-TAG-CAG-ATG-
ACG-AAC-ACG-CC-3V for cyclin D2; 5V-CCG-TGA-
TTG-CGC-ACG-ACT-TC-3V and 5V-TCT-GTG-GGA-
GTG-CTG-GTC-TG-3V for cyclin D3;5V-AGC-GAG-GAT-
AGC-AGT-CAG-CC-3V and 5V-TTT-CAT-CCC-CGG-
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CAA-CGG-ATT-TGG-C-3V and 5V-CAT-GTA-GGC-CAT-
GAG-GTC-CAC-CAC-3V for G3PDH (an endogenous
control). The quantitative conditions of the PCR reaction
were 28 or 31 cycles of 1 min at 948C, 1 min at 588C, and
1 min at 728C. The size of each PCR product was
confirmed by electrophoresis using 1% agarose gels in
TAE buffer. The RT-PCR products were semiquantified by
NIH image software (NIH, Bethesda, MD, USA, Version
1.60) and were expressed as relative amounts in relation to
the PCR product of G3PDH mRNA.
Cell proliferation assay
Cell-Counting Kit-8 solution (Wako Pure Chemical)
(Ishiyama et al., 1996) was added to a medium containing
the cells in a 96-well dish reacted at 378C for 1 h, according
to the manufacturer’s instructions. The number of viable
cells was measured at OD 450 nm using a Microplate
Reader (Bio-Rad).
Assay of apoptosis in vivo and in vitro
Apoptotic cells in the mammary glands of transgenic mice
were examined by the In Situ Cell Death Detection Kit
(Boehringer Mannheim) together with the TUNEL method.
The extent of apoptosis observed is indicated here as the
number of apoptotic nuclei counted as a percentage of the
total cells visualized. For the in vitro assay of apoptosis,
WAP-clonal cells were analyzed according to a previously
reported method (Li et al., 1999). Equal numbers of clones of
WAP-clonal HC11 cells and nontransfected (control) cells
were cultured for 2 days in a 12-well dish. The cells were
rinsed once with PBS and fixed with 3% paraformaldehyde at
48C overnight, washed three times with PBS, and then treated
with 0.1% Triton X-100 at room temperature for 15 min.
After being rinsed with PBS three times, the cells were
stained with 1 Ag/ml of Hoechst 33342 (Sigma) solution on
PBS–glycerol (vol/vol 1:1) at room temperature for 30 min.
The number of condensed or fragmented nuclei among the
cells in a dish was calculated under a fluorescence micro-
scope at an excitation wavelength of 365 nm.
Cell cycle analysis
Incorporation of bromodeoxyuridine (BrdU) into the
cultured cells was determined by the recommended
protocol of the Cell Proliferation ELISA, BrdU (Roche).
For the FACScan analysis, adherent cells were trypsinized
and fixed in cold 70% ethanol for 4 h. Fixed cells were
washed with PBS and incubated with 5 Ag/ml of RNase A
(Sigma), and then the cells were stained with 25 Ag/ml of
propidium iodine (Aldrich Chemicals) for 15 min at 48C.
The stained cells were analyzed on a FACScan cyto-
fluorimeter equipped with the ModeFit LT Software
program (Verity).Examination of the paracrine action of WAP
The paracrine action of WAP produced in WAP-clonal
cells upon cell proliferation was investigated by the
following two methods. First, WAP-clonal HC11 cells
(#24) were cultured for 48 h after confluence was reached.
The culture medium was recovered and then exchanged for
medium in which control HC11 or NIH3T3 cells had been
cultured. After the medium exchange, cells were cultured
for 24, 48, 72, and 96 h, respectively, and assayed for
potential for cell proliferation according to the method
described in the bCell proliferation assayQ section. Secondly,
WAP activity was also investigated using transwell cell
culture chamber inserts (Corning Costar). WAP-clonal cells
(104/chamber) were seeded on an upper microporous
membrane (pore size, 0.4 Am) in a transwell filled with an
appropriate medium for HC11 or NIH3T3 cells; the control
HC11 or NIH3T3 cells (3  104/chamber) were seeded on
the glass cover of a lower plate. After 96 h of co-culture, the
cells on the glass cover were recovered and immunochemi-
cally stained with WAP antibody. Evidence for the absence
of endogenous WAP expression in the cells on the lower
plate was confirmed by RT-PCR using the total RNA
extracted from those cells after co-culture.
Immunocytochemistry
The cultured cells were fixed in 3% paraformaldehyde
in PBS for 20 min, then in PBS or PBS containing 0.5%
Triton X-100 for 15 min at 48C. After being washed in
PBS, the cells were blocked for 30 min in 8% skim milk in
PBS, and then were incubated with the rabbit anti-mouse
WAP polyclonal antibody in a 1/100 dilution overnight at
48C, followed by washing three times in PBS. The porcine
anti-rabbit rhodamine-conjugated secondary antibody
(DAKO Immunoglobulins) were applied at a 1/50 dilution
with 8% skim milk in PBS, and the cells were incubated
for 1 h. Images were observed by confocal microscopy
(Carl Zeiss).
Detection of WAP in the cultured medium
The WAP-clonal cells were cultured in complete medium
without FBS for 2 days after 80% confluence was reached in
medium containing 10% fetal bovine serum. The medium in
the dish was collected by centrifugation (10 min, 3000 rpm),
condensed in a Centricon YH-10 (Milipore), and stored at
808C until use. WAP protein was detected by Western
blotting, as described in the bMaterials and methodsQ
section.
Statistical analysis
Data were analyzed by Student’s t test. Differences
between the mean values were considered statistically
significant at P b 0.05.
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Phenotype of transgenic mice
First, to confirm the expression of WAP in various tissues
other than in the mammary glands of normal lactating mice,
we analyzed RNAs from various tissues by RT-PCR. WAP
mRNA was detected in muscle, liver, lung, and vagina
although the expression levels were very low compared with
those in the mammary glands (Fig. 1A).
To determine whether WAP plays a role in various
tissues other than the mammary gland, CAG/WAP trans-
genic mice were produced that ubiquitously expressed WAP.
Ten pups (six females and four males) were found to be
transgenic by Southern blot analysis (Fig. 1B) and by PCR
analyses of tail DNAs. The pups that were born from two
transgenic lines showed poor growth or death during
nursing. For example, all of the pups from the first
parturition of the #7 founder mother died while nursing
within 3 days after birth. In the third parturition of the #7
founder, we exchanged her pups for those born from a
normal female at 3 days after birth. All of the seven pups
born from the normal mother showed significantly retarded
growth under the nursing of the transgenic mother and died
3 days after the exchange, whereas the pups from the
transgenic mother grew normally under the nursing of a
normal mother.
We sacrificed pregnant and lactating transgenic females
and collected their tissues. Northern blot analyses showed
that the female #7 transgenic founder expressed the
exogenous WAP gene at a high level in various tissues,Fig. 1. Representative WAP expression in normal lactating mice and
analyses of transgenic mice. (A) RT-PCR of WAP expression in various
tissues on day 14 of lactation. An aliquot of 1/100 of entire RT products
from RNA of the mammary glands was used for PCR. G3PDH mRNAwas
used as an internal control. Ma, mammary gland. WAP was expressed in
several tissues as well as in the mammary gland; Mu, muscle; Li, liver; Su,
submandibular gland; Lu, lung; Ut, uterus; Va, vagina; Cr, cerebrum; Cl,
cerebellum; P, positive control (pCX/WAP); N, negative control. (B)
Southern blot analysis of four of the resultant transgenic founders. Genomic
DNA from the tail was digested with EcoRI and hybridized with a WAP
cDNA probe. The 452-bp WAP transgene was excised by EcoRI; (C)
Northern blot analysis of a transgenic female of #7 founder (U7). S, spleen;
H, heart; Lu, lung; Li, liver; K, kidney; M, mammary gland; T, testis.including the mammary gland (Fig. 1C). Whole-mount
species of the mammary glands of this transgenic female
showed unique development (Fig. 2), including poor
development of lobulo-alveolar structures and acinous
formation considering the dam’s state of midpregnancy
(Fig. 2A) and lactation (Fig. 2B), compared with normal
mice (C and D in Fig. 2). The results from the examination
of mammary glands of transgenic females suggested that the
synthesis of milk proteins was inadequate, causing retarded
growth or death of the pups. Despite the high expression of
the WAP transgene in various tissues, the #7 transgenic
mothers grew normally and showed normal parturition and
nursing behavior. One other transgenic founder showed
slight impairment of the development of the mammary
gland, but her pups nonetheless grew normally.
The transgenic female offspring of eight other transgenic
founders showed no abnormalities of the mammary glands.
The hematoxylin and eosin stained transverse sections
showed that the development of the lobulo-alveolar struc-
tures was remarkably impaired in the transgenic tissues (A
and C in Fig. 3) compared with that of normal mammary
tissue (B and D in Fig. 3). Exogenous WAP was expressed
extensively in the mammary glands of pregnant and
lactating transgenic females. This expression was observed
not only in the alveolar gland, but also in other connective
tissues (E and G in Fig. 3). WAP was not yet expressed in
the mammary glands of normal 10-day-pregnant females (F
in Fig. 3). To determine the cause of impaired lobulo-
alveolar development in transgenic mice, we used the
TUNEL method to investigate the rate of extent of apoptosis
in the lobulo-alveolar structures. No significant apoptosis
was observed in the lobulo-alveolar cells of transgenic mice
(data not shown).
Effects of forced WAP expression on proliferation of
mammary epithelial cells
We first investigated the effects of the plasmid trans-
fection on the proliferation of HC11 cells by transient
expression of exogenous WAP. The transfection of empty
plasmids (mock) or EGFP plasmids did not affect the
relative numbers of live cells in either the HC11 or NIH3T3
cells (Fig. 4). The number of live cells among HC11 cells
transfected with WAP plasmids was significantly (P b 0.05)
lower at 2 days of culture after plasmid transfection,
compared with the number of live cells in the mock or
EGFP plasmid groups. This difference was not observed in
the case of NIH3T3 cells.
Next, we used the clonal HC11 (#24), EpH4K6 (#19),
and NIH3T3 cells (#13), which showed the highest levels of
stable WAP expression among the established clones. For
HC11 cells, we used other WAP-clonal cells (#59) that had
an expression level approximately one third of that of the
clone #24 cells as an additional clone of HC11 cells. The
production of WAP in WAP-clonal cells and its secretion
into the cultured medium were confirmed. We detected
Fig. 2. Whole-mount observation of mammary glands from normal (non-Tg) and transgenic mice (Tg) on day 10 of pregnancy (P10) and on day 7 of lactation
(L7). Lobulo-alveolar structures were significantly impaired in the transgenic mice (A, B) compared to the normal mice (C, D). Note that the sizes of the main
ducts in the transgenic mammary glands do not differ significantly from those of the normal mammary glands.
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and NIH3T3#13) (a in Fig. 5A). Immunoblot analysis
showed that WAP-clonal cells expressed WAP and secreted
it into the cultured medium: A 14-kDa WAP protein was
detected in cell extracts prepared from the WAP-clonal cells
(b in Fig. 5A), and it was also detected in the cultured
medium (c in Fig. 5A).
We investigated the effects of WAP expression on the
proliferation of WAP-clonal cells and found a significant
inhibition of cell proliferation in WAP-clonal HC11 cells
(#24) at 48 h after of culturing, compared with that of
nontransfected cells (Fig. 5B); moreover, the inhibitory
effect became even more significant at 96 h. Significant
inhibition of cell proliferation in the WAP-clonal HC11#59
cells was not observed until 96 h of culturing. Inhibitory
effects of WAP expression on cell proliferation were also
shown in WAP-clonal EpH4/K6 cells (Fig. 5B). There was
no difference in the proliferation of NIH3T3 cells between
the nontransfected and WAP-clonal cells throughout the
culturing period, although the expression of WAP transgene
was rather higher than that of WAP-clonal cells (#24) (data
not shown).
Paracrine action of WAP
In the subsequent experiments, HC11#24 cells that
showed the highest expression of WAP transgene among
the clones were used as the representative mammary
epithelial cells. To investigate the function of extracellular
WAP secreted from WAP-clonal cells, the nontransfected
cells were cultured in the cultured medium of WAP-clonal
cells. The experiments involving the exchange of cultured
medium showed that the cultured medium of WAP-clonal
cells significantly inhibited the proliferation of controlHC11 cells at 48 h of culture after medium exchange, but
not that of NIH3T3 cells (Fig. 6A). This effect increased
with the passage of time during the culture period. To test
for the paracrine action of WAP, we used a co-culture
system with a transwell insert. WAP-clonal cells were
cultured on transwell inserts and placed over control HC11
or NIH3T3 cells that had been seeded without WAP
expression. As shown in Fig. 6B, the WAP secreted from
the WAP-clonal HC11 cells was vectorially transported and
was able to bind to control HC11 cells without WAP
expression. In contrast, NIH3T3 cells were not stained with
the antibody against WAP, thereby indicating that trans-
ported WAP does not bind to NIH3T3 cells.
Effects of WAP on cell cycle and cyclins
To determine how the proliferation of HC11 cells was
inhibited by forced WAP expression, we first examined
apoptosis in the WAP-clonal HC11 cells. There was no
difference in the number of condensed or fragmented nuclei
between WAP-clonal cells and nontransfected cells; the rate
of apoptosis in nontransfected cells was 1.72% (total cell
number of control HC11 cells investigated = 407 cells), and
rates among the four clones ranged from 1.62% to 1.91%
(total cell number of four WAP-clonal cell lines = 1894
cells).
Next, we examined the BrdU incorporation and the
proportion of cell cycle progression in the WAP-clonal cells.
The percentage of BrdU-positive cells was significantly
lower in the WAP-clonal cells than in the nontransfected
HC11 cells or the WAP-clonal NIH3T3 cells (Fig. 7A). We
further investigated the effects of WAP on cell cycle
progression by FACScan. The proportion of WAP-clonal
HC11 cells in the G0/G1 phase showed higher than the
Fig. 4. Effects of transfection and transient WAP expression on the proliferation of growing HC11 and NIH3T3 cells. The expression of EGFP and the
transfection of mock plasmids did not affect proliferation of any of the cells used in this study. The WAP forced expression significantly (*P b 0.05) inhibited
the proliferation of HC11 cells but not that of HIH3T3 cells. The transgene expression was normalized by G3PDH expression as an internal control. The results
represent the mean of triplicate experiments and are expressed as number of cells. The values indicate the means F SEM of three experiments.
Fig. 3. Immunohistochemical examination of mammary tissues from normal and transgenic mice at 10 days of pregnancy (P10) and 7 days of lactation (L7).
Pups born from the transgenic female were exchanged by those from a normal female at 3 days after parturition. The glands from pregnant and lactating
transgenic mice (Tg) indicate very impaired development of lobulo-alveolar cells compared with those from normal mice (non Tg). WAP was not yet expressed
in mammary tissue of normal mice at 10 days of pregnancy (F), whereas WAP was expressed over an extensive area of mammary tissue of transgenic mice
(E, G). HE, hematoxylin and eosin staining (A, B, C, and D); WAP, immunostained with an antibody to WAP(E,F, G, and H); Arrows indicate mammary
glands. *, muscle; +, fat tissue; Original magnification, 100.
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Fig. 5. Effects of WAP expression on the proliferation of WAP-clonal cells. (A) Determination of WAP production in WAP-clonal cells and its secretion into
medium. (a) mRNA, RT-PCR of RNAs from cells; (b) Cell lysate, Western blot of cell lysate from cells; (c) Conditioned medium, Western blot of serum-free
medium in which cells were cultured for 48 h. (B) Time course of proliferation of WAP-clonal HC11, EpH4/K6, and NIH3T3 cells after the start of culturing.
The proliferation of WAP-clonal mammary epithelial cells was significantly depressed at 48 h in HC11#24, at 96 h in HC11#59, or at 72 h in EpH4/K6#13 of
culturing. The expression level of WAP in HC11#59 was approximately one third of that of HC11#24 cells. Proliferation was not affected in NIH3T3 cells by
WAP expression throughout the culture period. The results represent the means F SEM of three experiments. WT, nontransfected; #13, #19, #24, and #59,
clone number; *P b 0.05; **P b 0.01.
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(Fig. 7B). In contrast, there was no difference in cell cycle
proportions between nontransfected cells and WAP-clonal
cells among the NIH3T3 cells. The G0/G1 phase was longer
in the WAP-clonal HC11 cells than in the nontransfected
HC11 cells. The cells were cultured in conditioned medium
after being synchronized at the G0 phase, and they were
subsequently analyzed by FACScan; it was found that the
proportion of WAP-clonal HC11 cells that remained in the
G0/G1 phase was significantly higher (81.1%) than that of
the nontransfected HC11 cells (61.5%) at 12 h of culturing.
The FACScan analysis also demonstrated that forced WAP
expression did not enhance apoptosis in HC11 cells.
Finally, we investigated the effects of WAP on the
expression of the G1-phase cyclins D1, D2, D3, and E usingWAP-clonal HC11and NIH3T3 cells. The summarized
results of these RT-PCR analyses are shown in Fig. 8A.
The expression of both cyclin D1 and D3 was significantly
lower in WAP-clonal cells than in the control cells: The
expression of these cyclins was low in HC11 cells in the
presence of WAP expression. There was no difference in the
expression of the G1 phase cyclins between WAP-clonal
cells and control NIH3T3 cells. No overt differences in
either cyclin D2 or cyclin E expression were observed
among WAP-clonal HC11 cells or control cells. Western
blot analyses confirmed the depression of cyclin D1 and D3
expression in WAP-clonal HC11 cells (Fig. 8B). To further
confirm the inhibitory effects of WAP against cyclin D1
expression, we cultured WAP-clonal HC11 and control
HC11 cells that were synchronized to the G0 phase in
Fig. 6. Evidence for the paracrine activity of WAP secreted fromWAP-clonal cells. (A) Inhibitory effect of medium in which WAP-clonal cells were cultured on
the proliferation of nontransfected HC11 or NIH3T3 cells. WT, nontransfected HC11 cells; #13 and #24, clone number. Each data point indicates the means F
SEM of three experiments. *P b 0.05; **P b 0.025. (B) Immunocytochemical observation of vectorially transported WAP. WAP-clonal HC11 cells were co-
cultured with nontransfected HC11 and NIH3T3 cells for 96 h in a transwell insert system. WAP bound to nontransfected HC11 cells but not to NIH3T3 cells.
Binding of WAP to HC11 cells was dissolved by Triton treatment (+Triton).
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were examined for the expression of cyclin D1 with a time-
lapse culture. The elevation of cyclin D1 expression was
significantly depressed in WAP-clonal HC11 cells at 10 h of
culture after the cells were synchronized in the G0 phase,
compared to that in the control HC11 cells (C and D in Fig.
8). In particular, we noted that the mean amount of cyclin
D1 produced in the WAP-clonal HC11 cells was about half
of that in the control HC11 cells at 12 h of culturing (P b
0.05) (Fig. 8D).Discussion
In vivo experiments
To date, some insights regarding the possible functions of
WAP have been proposed. For example, Robinson et al.
(1995) studied WAP/WAP transgenic mice in which WAP is
synthesized precociously, and they proposed a model for the
regulation of mammary alveolar cell differentiation whereby
the precocious expression of WAP results in the terminal
differentiation of alveolar cells already at midpregnancy,
which in turn prevents the alveolar structures fromproliferating. However, only a few attempts at determining
the function of WAP have previously been carried out
(Burdon et al., 1991a,b; Robinson et al., 1995; Shamay et
al., 1992); this lack of investigative reports is likely to the
fact that WAP had previously been identified in the milk of
only a limited number of mammalian species (Beg et al.,
1984; Campbell et al., 1984; Devinoy et al., 1988;
Hennighausen and Sippel, 1982a). In recent years, WAP
has also been identified in the milk of pigs (Rival et al.,
2001; Simpson et al., 1998), wallabies (Simpson et al.,
2000), red kangaroos (Nicholas et al., 2001), and brushtail
possums (Demmer et al., 2001).
Our results indicate that precocious and ubiquitous
expression of WAP impairs only the development of
mammary glands; it does not appear to inhibit other
physiological functions in transgenic females. On the other
hand, it has been reported that MMTV-LTR/WAP trans-
genic mice show hyperplasia of the coagulation gland
epithelium in addition to impaired mammary development
(Hennighausen et al., 1994). The discrepancy in pheno-
types between CAG/WAP and MMTV-LTR/WAP trans-
genic mice may be attributable to the difference in
expression level of WAP transgene in the coagulation
glands owing to the different transgene. The lobulo-alveolar
Fig. 7. Effects of forced WAP expression on cell cycle progression of HC11 cells. (A) Comparison of BrdU incorporation in WAP-clonal HC11 and NIH3T3
cells. The values indicate the percentages of BrdU incorporated into cells (BrdU/cell) at 4 h after BrdU was added. The incorporation of BrdU in HC11 cells
was significantly lower (*P b 0.05) in WAP-clonal cells (WAP clone) than in nontransfected cells (WT). The values indicate the means F SEM of three
experiments. (B) FACScan analysis of WAP-clonal HC11 and NIH3T3 cells. Cells were cultured for 96 h, and the adherent cells were trypsinized, fixed in 70%
ethanol, stained with propidium iodide, and analyzed on a FACScan cytofluorimeter (see "bMaterials and methodsQ section for details). HC11 (synchronized),
HC11 cells were synchronized. Numbers indicate the percentages of cells in different phases of the cell cycle.
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mice were found to resemble those of midpregnant,
nontransgenic mice. The marked epithelial cell proliferation
that usually occurs during days 15–19 of pregnancy was
absent, indicating that partial alveolar cells failed to
develop functionally. Poor lobulo-alveolar development
caused agalactia and resulted in the death of pups born
nursing with an affected mother. These findings clearlydemonstrate that WAP regulates the development of the
mammary glands of females throughout late pregnancy and
lactation. Because it has been postulated that the mammary
glands of these transgenic mice are under the normal
control of various lactogenic hormones, as are those of
normal mice during pregnancy and lactation (Lyons, 1958),
it is thought that precocious expression and overexpression
of WAP inhibit alveolar development, working against the
Fig. 8. Effects of forced WAP expression on synthesis of cyclin proteins. (A) RT-PCR analysis of the expression of G1-phase cyclins (cyclin D1, D2, and D3)
and cyclin E in WAP-clonal HC11 and NIH3T3 cells that were cultured for 96 h. RT-PCR products were semiquantified by NIH image software and were
expressed as relative amounts in relation to the PCR product of G3PDH mRNA. The values indicate the means F SEM of three experiments. WT,
nontransfected cells; #13 and #24, WAP-clone number. (B) Western blot analysis of cyclin D1, D3, E, and CDK4 in cultured cells at 96 h of culturing. (C)
Western blotting of cyclin D1 and CDK4 in WAP-clonal HC11 cells that were cultured in conditioned medium for 0, 10, 12, and 14 h after the cells were
synchronized in the G0 phase. The elevation of cyclin D1 expression was significantly depressed in WAP-clonal HC11 cells at 10 h of culture. (D) Relative
amount of cyclin D1 protein expressed in WAP-clonal and nontransfected HC11 cells. The amount of cyclin D1 protein was semiquantified by NIH image
software and is indicated as the relative amounts in relation to the amount of CDK4 protein. The values indicate the means F SEM of three experiments.
*P b 0.05; **P b 0.025.
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impaired lobulo-alveolar development of our transgenic
mice very much resembled that of Id2 (the helix-loop-helix
inhibitor) null mice with a lactation defect (Mori et al.,
2000). Id2 null mammary glands exhibit a defect in cell
proliferation, significant BrdU incorporation, and enhanced
apoptosis. In our experiments, apoptosis was not enhanced
in the mammary glands of transgenic females. Therefore,
we believe that the mechanism underlying WAP function in
the epithelial proliferation of mammary glands differs from
that underlying Id2 function.It is noteworthy that ubiquitous expression and over-
expression of WAP did not appear to affect any overt
physiological function other than to induce impaired devel-
opment of the lobulo-alveolar cells of the mammary glands
in our transgenic mice. The present results may also help to
explain our previous findings of no histological or physio-
logical abnormalities in transgenic mice overexpressing the
WAP gene under the control of the metallothionein-I gene
promoter (Hase et al., 1996). Impairment of mammary gland
development in our transgenic females was not as severe as
that in WAP/WAP transgenic animals (Burdon et al., 1991b;
N. Nukumi et al. / Developmental Biology 274 (2004) 31–4442Shamay et al., 1992), possibly because the activity of the
WAP promoter overcomes that of the CAG promoter in the
mammary glands, resulting in tissue-specific expression.
In vitro experiments
The forced and high expression of exogenous WAP
significantly inhibited the proliferation of HC11 and EpH4/
K6 cells established from mammary glands, whereas it did
not affect that of NIH3T3 cells established from mouse
fibroblasts. The results of the experiments involving
medium exchange and a co-culture system with a transwell
insert demonstrated that WAP acts on HC11 cells through a
paracrine mechanism. The finding that vectorially trans-
ported WAP binds to HC11 cells but not to NIH3T3 cells
clearly indicates that the inhibitory action of WAP on cell
proliferation is specific to mammary epithelial cells. Our
BrdU incorporation and FACScan analyses indicated that
the cell cycle progression from the G0/G1 phase to the S
phase was inhibited in WAP-clonal HC11 cells and also
apoptosis was not enhanced in those cells. RT-PCR and
Western blot analyses of the expression of G1-phase cyclins
demonstrated that forced WAP expression in HC11 cells
significantly depresses the expression of cyclins D1 and D3,
but does not affect the expression of other cyclins such as
cyclins D2 and E.
D-cyclins are core components of the cell cycle (Sherr
and Roberts, 1999), and they show significant amino acid
similarity (Inaba et al., 1992; Xiong et al., 1992). Cyclin D1
is believed to play a critical role in the progression from the
G1 to the S phase of the cell cycle. Overexpression of cyclin
D1 is seen in a large number of human cancers, including
mammary and liver cancer (Bartkova et al., 1995; Dickson
et al., 1995; Weinstat-Saslow et al., 1995), and transgenic
mice overexpressing cyclin D1 under the control of the
mouse mammary tumor virus (MMTV) promoter develop
mammary carcinomas (Wang et al., 1994). In contrast, adult
female mice lacking cyclin D1 fail to undergo the massive
epithelial proliferation of mammary glands during preg-
nancy, despite normal levels of ovarian steroid hormones
(Sicinski et al., 1995). Thus, cyclin D1 has been found to
regulate the epithelial proliferation of mammary glands.
The results of our in vivo and in vitro experiments, when
taken together with those of previous studies of WAP/WAP
transgenic animals (Burdon et al., 1991b; Robinson et al.,
1995; Shamay et al., 1992), strongly indicate that WAP may
play a role in the cell cycle progression of mammary
epithelial cells during pregnancy and lactation, in particular
at the point in the cycle from G1 to S-phase entry, via the
regulation of cyclin D1 expression. Cyclin-D3-deficient
mice have also been found to be viable, but they display
lymphoid abnormalities (Ciemerych et al., 2002). A
previous study of mice expressing a single D-type cyclin
showed that cyclin-D3-only mice have abnormal cerebra
(Ciemerych et al., 2002). In our study, the expression of
cyclin D3, as well as that of cyclin D1, significantlydecreased in WAP-clonal cells in comparison to control
cells; however, the mechanism responsible for the decrease
in cyclin D3 expression and WAP function in WAP-clonal
HC11 cells remains obscure.
The WAP proteins contain four-disulfide (4-DSC)
domains, and each disulfide domain is composed of
approximately 50 amino acids, including eight cysteine
residues in a conserved arrangement. The WAP motif,
consisting of two 4-DSC domains, is found in several other
proteins with membrane-adhesion properties or with inhib-
ition properties, suggesting that its motif is important with
regard to the biological role of these proteins (Ranganathan
et al., 2000; Simpson et al., 2000). A variety of mucosal
proteins that are composed of one or multiple copies of a 4-
DSC domain have shown protease-inhibitor functions.
Based on the limited sequence identity of WAP with known
protease inhibitors, it has been suggested that WAP may be
a protease inhibitor. If WAP does indeed posses protease
inhibitor activity, it may be directed against specific
protease(s). This putative WAP function is supported by
evidence showing no abnormalities in the physiology of the
present transgenic mice that express WAP ubiquitously.
Proteases and protease inhibitors are thought to regulate
tissue formation and remodeling during the development of
the mammary glands (Fata et al., 1999; Kramps et al., 1988;
Lee et al., 2000; Lyons et al., 1988). Therefore, it will be
necessary in future studies to consider WAP function in
terms of both protease–protease inhibitor interactions and
cell–cell interactions in the mammary gland.Acknowledgments
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